Skip to main content
Premium Trial:

Request an Annual Quote

Gentel, RayBiotech Co-developing Antibody Arrays

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Gentel Biosciences and RayBiotech today announced a partnership to develop and market RayBiotech's antibody array products for use with Gentel's APiX chromogenic detection platform.

RayBiotech's products cover a variety of cytokines and other proteins. The new kits combine the APiX technology and RayBiotech's collection of more than 55 antibody and protein arrays on a glass slide format. Each kit is configured for use on the Gentel Proteomics Multi-System and Gentel's AthenaQuant analysis software for an alternative to fluorescent-based detection.

APiX chromogenic detection enables detection of any biotinylated molecule, generating light gray to black spots both visible to the naked eye and scannable with the Gentel Proteomics Multi-System, the companies said in a joint statement.

The 49 new APiX Antibody Arrays can be purchased from Gentel, which said they are the third in a series of "high-value" products and services the Madison, Wis.-based firm is bringing to market in the second half of 2010.

Terms of the deal were not disclosed.